News & Updates

Major study delivers positive news for Kiwi prostate cancer patients

Tue Oct. 29th 2024

A prostate cancer diagnosis can feel overwhelming, but understanding treatment options can help patients actively participate in treatment decision making.
A recent international study highlights the benefits of Stereotactic Body Radiation Therapy (SBRT), offering men with early-stage prostate cancer more options for treatment.
With cutting-edge technology like CyberKnife, patients in Aotearoa now have access to advanced, non-invasive treatment options.
Click to learn more about the trial results, SBRT and CyberKnife in our article.

A fond farewell to Tracey Gray

Tue Oct. 15th 2024

Tracey has been part of ARO since the day our doors opened over 16 years ago. During her time she’s made an incredible impact on both staff and patients, bringing exceptional expertise and warmth to her role as a radiation therapist.

Nancy Yang, radiation therapist graduates from Foundational Leadership Training

Tue Oct. 1st 2024

Congratulations to Nancy Yang, one of ARO's talented radiation therapists, who has recently graduated from Foundational Leadership Training. Find out what working in oncology means to Nancy and how she discovered her path to best serving patients.

Auckland Radiation Oncology and Cancer Society Auckland Northland celebrate renewed sponsorship partnership

Wed Aug. 14th 2024

The renewal of this partnership is a clear demonstration of the continued commitment from both ARO and CSAN to improve cancer outcomes for patients.

Celebrating Excellence: ARO Values in Action Awards

Sat Aug. 3rd 2024

A Day of Celebration and Support

The awards ceremony recognised exemplary team members living our ARO Values in Action Awards. This was a day to recognise the hard work and commitment of our staff and also supported Mercy Hospice, an organisation dear to our hearts.

Leading with Warmth: ARO Reception Team sets the Tone

Wed July 3rd 2024

Meet Veena, one of ARO’s welcoming reception team. We think her role is vital at ARO, as she is often the first person new patients meet when they walk through our doors, and she’s also the friendly face that welcomes them back each day for their treatment.

Prostate Cancer in New Zealand: Improvements in Treatment and Outcomes

Mon June 24th 2024

There are a number of options for treating prostate cancer. The best approach will be individual to each patient and will consider how advanced the cancer is, and the general health of the patient.

New Information for Prostate Cancer Patients

Fri June 14th 2024

Positive patient feedback and the number of inquiries about CyberKnife and prostate cancer has prompted ARO to create a dedicated area on their website to provide more information and explain how CyberKnife helps prostate cancer patients get back to a normal life sooner.

Nimitha John: The Sacrifices and Rewards of Nursing

Fri May 10th 2024

Meet Nimitha John, a highly experienced nurse at ARO, whose personal journey led her to specialise in oncology. Discover her reflections on nursing, shaped by her experiences in both India and Aotearoa, and understand why this profession holds such importance for her.

ARO North Shore Site Blessing Signals Start of Construction

Fri May 3rd 2024

This week marked an important moment for the construction of ARO’s new treatment centre for the North Shore. Following a blessing by Kaumātua, Eruera Morgan, the first shovel broke the ground in a soil turning ceremony attended by Joseph Stafford, Andrew Wong, the ARO leadership team, directors and key partners involved in the construction programme.

Celebrating One Year of CyberKnife at ARO: A Remarkable Journey in Cancer Treatment

Mon Dec. 18th 2023

CyberKnife – ARO's newest treatment machine has officially turned one year old!. 12 months have passed since ARO treated thier first brain cancer patient with CyberKnife, setting the stage for a remarkable journey in the field of cancer treatment.

Breakthroughs in Prostate Cancer Treatment

Wed Nov. 1st 2023

Study finds that after five years, 96% of the men who received five doses of the multi-beam radiotherapy were cancer-free, compared to 95% who received at least 20 doses of standard radiotherapy.